Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;65(1):189-203.
doi: 10.1007/s12088-024-01296-5. Epub 2024 May 27.

Microfluidic Systems: Recent Advances in Chronic Disease Diagnosis and Their Therapeutic Management

Affiliations

Microfluidic Systems: Recent Advances in Chronic Disease Diagnosis and Their Therapeutic Management

Swadha Pandey et al. Indian J Microbiol. 2025 Mar.

Abstract

Microfluidics has advanced the area of diagnostics during the past ten years by offering fresh approaches that weren't achievable with traditional detection and treatment techniques. High-throughput operations can be carefully controlled by using microfluidics and are very cost-effective too. It has been accepted to be a quick and effective method for controlled medication delivery, biological sample preparation, and analysis. This new technology has made it possible to create a wide range of micro and nanocarriers for poorly soluble medications, which has many advantages over traditional drug delivery techniques. Furthermore, a targeted medication delivery system utilizing microfluidic technology can be developed to enhance the drug's local bioavailability. Over the years, extensive R&D in microfluidic technology has led to the creation of various advanced applications in both laboratory and consumer biotechnology. Miniaturized genetic and proteasome analyzers, cell culture and control platforms, biosensors, disease detection, optical imaging devices, diagnostic advanced drugs, drug delivery schemes, and innovative products are some of the advanced applications of the microfluidics system. Also, these are highly adaptable microfluidic tools for disease detection and organ modeling, as well as transduction devices used in biomedical applications to detect biological and chemical changes. Beyond the specialized difficulties in studying cell-cell interactions, microfluidics has several difficulties in biomedical applications, especially for diagnostic devices where minute interactions can lead to imprecise evaluations. Assay function can be significantly changed by the way plastics, adhesives, and other materials interact. Therefore, the foundation of microfluidic technology needs to be grounded in real-world uses that can be produced on a big scale and at a reasonable cost. Further, it is a very interdisciplinary field that requires the collaboration of professionals in fluidics, assay science, materials science, and instrumentation to provide devices with the proper and needed functionality. In this article, we have discussed the advanced disease diagnosis and their therapeutic management which will help to understand the current scenario in the field of microfluidics diagnosis and will fill knowledge about the 'gap' in the system.

Keywords: Chronic diseases; Disease diagnosis; Microfluidic systems; Therapeutic aspects.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that there is no conflict of interest regarding the publication of this manuscript.

Similar articles

References

    1. Singh A, Agarwal R, Diaz-Ruiz CA, Willett NJ, Wang P, Lee LA, Wang Q, Guldberg RE, García AJ (2014) Nanoengineered particles for enhanced intra-articular retention and delivery of proteins. Adv Healthc Mater. 10.1002/adhm.201400051 - PMC - PubMed
    1. Duncanson WJ, Lin T, Abate AR, Seiffert S, Shah RK, Weitz DA (2012) Microfluidic synthesis of advanced microparticles for encapsulation and controlled release. Lab Chip 12:2135–2145 - PubMed
    1. Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–1268 - PMC - PubMed
    1. Avesar J, Arye TB, Levenberg S (2014) Frontier microfluidic techniques for short and longterm single cell analysis. Lab Chip 14:2161–2167 - PubMed
    1. Wu J, Kong T, Yeung KWK, Shum HC, Cheung KMC, Wang L, To MKT (2013) Fabrication and characterization of monodisperse PLGA–alginate core–shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomater 9:7410–7419 - PubMed

LinkOut - more resources